Gunderson Dettmer advised TeneoTwo on the deal. TeneoTwo, a developer of therapeutic antibodies, announced its pending acquisition by AstraZeneca, a bio-pharmaceutical company that focuses on the discovery,...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer represented Ancora Biotech on the deal. Ancora Biotech, a California-based biotechnology company, announced its $60 million Series A financing co-led by Lightspeed Venture Partners and...
You must be a Standard 1 Year member to access this content.
Cravath, Swaine & Moore represented RELX in the transaction while Gunderson Dettmer represented BehavioSec. LexisNexis® Risk Solutions, part of RELX, a global provider of information-based analytics...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz represented SoFi in the transaction while Gunderson Dettmer advised Technisys. SoFi Technologies, Inc., the digital personal finance company, has entered into a...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Carto on the deal. Carto, a cloud-native spatial analysis platform, announced its $61 million Series C financing led by...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Theseus Pharmaceuticals on the deal. Theseus Pharmaceuticals, Inc., a biopharmaceutical company focused on improving the lives of cancer...
You must be a Standard 1 Year member to access this content.
Goldman Sachs & Co. acted as financial advisor to Amgen and Latham & Watkins as its legal advisor. Gunderson Dettmer Stough Villeneuve Franklin & Hachigian and...
You must be a Standard 1 Year member to access this content.
